XI. národní kongres ČSTH & 30. česko-slovenská konference o trombóze a hemostáze

Zahraniční hosté

Prof. dr. Frits Rosendaal

Professor Clinical Epidemiology

Frits Rosendaal is professor of Clinical Epidemiology and chair of the department of Clinical Epidemiology in the LUMC. His research is into causes of cardiovascular disease. In 2003 he received the Spinoza prize, the highest scientific award in the Netherlands. He is elected fellow of the Royal Academy of Science and Arts, as well as of the German Academy Leopoldina. In 2011 he was awarded a honorary doctorate of the University of Paris Descartes. He is Editor in Chief of Research Integrity and Peer Review and of the Geneesmiddelenbulletin, vice-chair of the Central Committee of Research on Humans (CCMO), member of the Committee on publication ethics (COPE), chair of the Research Integrity policy group of the LERU universities, and co-chair of the Scientific Integrity Committee of the University Leiden and the LUMC. He also teaches at the Universita degli Studi di Milano in Milan, Italy.

Dr. med. Anna Pavlova

University Hospital Bonn in Germany

Dr. med. Anna Pavlova is a medical professional specializing in Molecular Hemostaseology at the University Hospital Bonn in Germany. She works at the Institute of Experimental Hematology and Transfusion Medicine (IHT). Dr. Pavlova holds the position of Oberärztin (Senior Physician) and is part of the leadership team for the Molecular Hemostaseology and HLA Diagnostics department at the institute. Her work focuses on the study of blood coagulation at the molecular level, which is crucial for understanding and treating various bleeding disorders. As part of her role, Dr. Pavlova is involved in diagnostic services related to hemostasis disorders. The institute where she works is accredited by the European Federation for Immunogenetics (EFI), indicating its high standards in immunogenetics and histocompatibility testing.

Dr. Pavlova's research interests appear to include rare genetic bleeding disorders, such as Factor VII deficiency, which is characterized by deficient or reduced activity of coagulation Factor VIII. Her work likely involves both clinical practice and research, contributing to the field of hematology and transfusion medicine. Her expertise in molecular hemostaseology plays a crucial role in the diagnosis and management of complex blood disorders at this leading medical institution.